Vorolanib structure
|
Common Name | Vorolanib | ||
|---|---|---|---|---|
| CAS Number | 1013920-15-4 | Molecular Weight | 439.48 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H26FN5O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of VorolanibVorolanib (CM082; X-82) is an orally active, multikinase VEGFR/PDGFR inhibitor. Vorolanib minimizes toxicity, disrupts tumor angiogenesis and tumor cell proliferation, and induces of tumor cell death[1]. |
| Name | Vorolanib |
|---|---|
| Synonym | More Synonyms |
| Description | Vorolanib (CM082; X-82) is an orally active, multikinase VEGFR/PDGFR inhibitor. Vorolanib minimizes toxicity, disrupts tumor angiogenesis and tumor cell proliferation, and induces of tumor cell death[1]. |
|---|---|
| Related Catalog | |
| Target |
VEGFR, PDGFR[1] |
| References |
| Molecular Formula | C23H26FN5O3 |
|---|---|
| Molecular Weight | 439.48 |
| X-082 |